Isavuconazole (Cresemba®) for the treatment of invasive aspergillosis.

Assessment Status Rapid Review Complete
Drug Isavuconazole
Brand Cresemba®
Indication For the treatment of invasive aspergillosis
Assessment Process
Rapid review commissioned 11/04/2016
Rapid review completed 11/05/2016
Rapid review outcome Full Pharmacoeconomic Assessment Recommended at the submitted price

The HSE has approved reimbursement following confidential price negotiations: April 2018.